ENvue Medical (FEED) filed an 8-K on 2026-01-30 revealing a material negative structural change: the company removed the floor price on its Series H Convertible Preferred Stock in exchange for only $2.5M in new capital.
What Changed
The amendment eliminates downside protection for common shareholders:
- New conversion price: 85% of the average of the 3 lowest VWAPs over 10 trading days
- No floor price: Previously had a floor to prevent unlimited dilution; now removed
- Full ratchet anti-dilution remains: Any future dilutive issuance automatically adjusts conversion price downward
Death Spiral Mechanics
This creates a self-reinforcing dilution cycle:
- Preferred converts at 85% of recent lows (15% discount)
- Conversion selling pressure drives price down
- Next conversion happens at even lower price (no floor to stop it)
- Full ratchet means any other dilution also lowers conversion price
- Cycle repeats until common equity approaches zero
Distress Signals
The tiny raise amount ($2.5M) relative to the massive structural concession (removing all downside protection) indicates severe financial distress. Companies with access to better capital terms don't give away unlimited dilution protection for such small amounts.
Market reaction confirms:
- Stock down -15.9% on filing day
- Currently at $3.23, down -95% over 1 year
- Trading at 1% of 52-week range ($0.99 - $162.50)
- Volume spike: 66.7M shares (191.9× weekly average)
- Idiosyncratic volatility: 277.1%
Investment Implications
Avoid all long positions. Common shareholders face uncapped dilution risk with no floor price protection. The combination of death spiral structure, full ratchet anti-dilution, and minuscule raise amount for maximum structural concession is characteristic of pre-insolvency financing.
This is a potential short candidate for portfolios with short capability, or at minimum a "never touch" flag for long portfolios.
// comments (0)